Salipro Japan patent PR
Salipro Biotech Expands Global Intellectual Property Portfolio with Granted Patent in Japan
13 juin 2023 07h00 HE | Salipro Biotech AB
Salipro Biotech obtains granted patent in Japan, protecting its proprietary Salipro® platform technology to enable the development of therapeutics against challenging drug targets, including GPCRs,...
ZyversaREV_cmyk.jpg
European Patent Office to Grant ZyVersa Therapeutics’ Patent Application for Cholesterol Transport Mediator™ VAR 200 for Use in Patients with Diabetic Nephropathy/Diabetic Kidney Disease
06 juin 2023 09h07 HE | ZyVersa Therapeutics
Cholesterol Transport Mediator™ VAR 200 is in development to reduce renal cholesterol and lipid accumulation that damages the kidneys' filtration system in patients with glomerular diseases, including...
Anaqua_Logo_Large_Full_Color.png
Getinge Selects Anaqua to Provide Single, Centralized IP Management Platform
06 juin 2023 04h06 HE | Anaqua
BOSTON, June 06, 2023 (GLOBE NEWSWIRE) -- Anaqua, the leading innovation and intellectual property (IP) management technology provider, today announced that global medical technology company...
Anaqua_Logo_Large_Full_Color.png
Getinge wählt zentralisierte IP-Management-Plattform von Anaqua
06 juin 2023 04h06 HE | Anaqua
BOSTON und MÜNCHEN, June 06, 2023 (GLOBE NEWSWIRE) -- Anaqua, der führende Technologieanbieter für Innovation und Management von geistigem Eigentum (IP), gab heute bekannt, dass sich das...
AB Science announces
AB Science announces issuance of a Canadian patent for masitinib in the treatment of ALS with protection until 2037
01 juin 2023 12h01 HE | AB Science
PRESS RELEASE AB SCIENCE ANNOUNCES ISSUANCE OF A CANADIAN PATENT FOR MASITINIB IN THE TREATMENT OF AMYOTROPHIC LATERAL SCLEROSIS (ALS) WITH PROTECTION UNTIL 2037 CANADIAN PATENT COMPLETES...
AB Science annonce l
AB Science annonce la délivrance d’un brevet canadien pour le masitinib dans le traitement de la SLA avec une protection jusqu’en 2037
01 juin 2023 12h01 HE | AB Science
PRESS RELEASE AB SCIENCE ANNONCE LA DÉLIVRANCE D'UN BREVET CANADIEN POUR LE MASITINIB DANS LE TRAITEMENT DE LA SCLÉROSE LATÉRALE AMYOTROPHIQUE (SLA) AVEC UNE PROTECTION JUSQU'EN 2037 CE BREVET...
Fresco.jpg
Fresco Secures US Patent for Proprietary KitchenOS Platform and AI Recipe Engine
31 mai 2023 09h00 HE | Fresco
DUBLIN, Ireland, May 31, 2023 (GLOBE NEWSWIRE) -- Fresco, the leading smart kitchen platform for the world’s appliance brands, announced today that it has been granted its first patent on its path...
Algernon Logo 1.png
Algernon Pharmaceuticals Receives Notice of Allowance from the Japanese Patent Office for Repirinast and the Treatment of CKD
31 mai 2023 07h19 HE | Algernon Pharmaceuticals
Vancouver, British Columbia, May 31, 2023 (GLOBE NEWSWIRE) -- Algernon Pharmaceuticals Inc. (CSE: AGN) (FRANKFURT: AGW0) (OTCQB: AGNPF) (the “Company” or “Algernon”), a clinical stage pharmaceutical...
Attachment.jpg
Mountain Valley MD Executes Soluvec™ 1% License Agreement, Expands Patent Protection
08 mai 2023 09h15 HE | Mountain Valley MD Holdings Inc.
TORONTO, May 08, 2023 (GLOBE NEWSWIRE) -- Mountain Valley MD Holdings Inc. (the “Company” or “MVMD”) (CSE: MVMD) (OTCQB: MVMDF) (FRA: 20MP) is pleased to announce that Mountain Valley MD Inc....
ViaLA_Full Logo_RGB.jpg
Via Licensing and MPEG LA Unite to Form Via Licensing Alliance, the Largest Patent Pool Administrator in the Consumer Electronics Industry
02 mai 2023 08h30 HE | Via Licensing Alliance LLC
SAN FRANCISCO and DENVER, May 02, 2023 (GLOBE NEWSWIRE) -- Via Licensing Corporation (Via) and MPEG LA, L.L.C. (MPEG LA) today announced they have united to form Via Licensing Alliance LLC (Via LA),...